[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark Joseph Vignola Ph.D.", "age": 45, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 974160, "exercisedValue": 0, "unexercisedValue": 35194}, {"maxAge": 1, "name": "Mr. Seokho  Yoon Esq.", "age": 45, "title": "COO, General Counsel & Secretary", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 921046, "exercisedValue": 0, "unexercisedValue": 35194}, {"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 53, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior VP & Head of Research", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 43, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 46, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1719619200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.11, "open": 7.15, "dayLow": 6.69, "dayHigh": 7.2, "regularMarketPreviousClose": 7.11, "regularMarketOpen": 7.15, "regularMarketDayLow": 6.69, "regularMarketDayHigh": 7.2, "beta": -0.417, "forwardPE": -4.970803, "volume": 5482979, "regularMarketVolume": 5482979, "averageVolume": 1080655, "averageVolume10days": 1676860, "averageDailyVolume10Day": 1676860, "bid": 6.78, "ask": 6.82, "bidSize": 400, "askSize": 400, "marketCap": 440451040, "fiftyTwoWeekLow": 3.26, "fiftyTwoWeekHigh": 8.75, "fiftyDayAverage": 6.2018, "twoHundredDayAverage": 5.896575, "currency": "USD", "enterpriseValue": 200224352, "floatShares": 23587755, "sharesOutstanding": 64677100, "sharesShort": 2296762, "sharesShortPriorMonth": 2234303, "sharesShortPreviousMonthDate": 1715731200, "dateShortInterest": 1718323200, "sharesPercentSharesOut": 0.0355, "heldPercentInsiders": 0.01788, "heldPercentInstitutions": 1.1935099, "shortRatio": 2.04, "shortPercentOfFloat": 0.0403, "impliedSharesOutstanding": 64677100, "bookValue": 3.661, "priceToBook": 1.8601475, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -91055000, "trailingEps": -1.26, "forwardEps": -1.37, "enterpriseToEbitda": -1.934, "52WeekChange": -0.17654175, "SandP52WeekChange": 0.22553468, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "TERN", "underlyingSymbol": "TERN", "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1612535400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7e7e889b-1f93-38a3-8cbf-64bb942bfd16", "messageBoardId": "finmb_558294166", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.81, "targetHighPrice": 22.0, "targetLowPrice": 5.5, "targetMeanPrice": 14.21, "targetMedianPrice": 15.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 240654000, "totalCashPerShare": 3.721, "ebitda": -103549000, "totalDebt": 427000, "quickRatio": 27.26, "currentRatio": 27.854, "debtToEquity": 0.18, "returnOnAssets": -0.23686, "returnOnEquity": -0.34727, "freeCashflow": -44619376, "operatingCashflow": -75806000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-30"}]